IHE:NYE-iShares U.S. Pharmaceuticals ETF (USD)

ETF | Health |

Last Closing

USD 65.88

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-11 )

ETFs Containing IHE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.24% 38% F 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.24% 38% F 71% C-
Trailing 12 Months  
Capital Gain 2.84% 65% D 50% F
Dividend Return 1.45% 94% A 23% F
Total Return 4.29% 67% D+ 41% F
Trailing 5 Years  
Capital Gain 23.35% 52% F 64% D
Dividend Return 8.86% 95% A 27% F
Total Return 32.21% 62% D 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 4.30% 48% F 48% F
Dividend Return 5.68% 52% F 45% F
Total Return 1.38% 100% F 34% F
Risk Return Profile  
Volatility (Standard Deviation) 15.39% 71% C- 66% D+
Risk Adjusted Return 36.92% 67% D+ 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike